# Michael T. Lotze

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-t-lotze/

## Facts

| Field | Value |
| --- | --- |
| Citations | 83,023 |
| Field | Immunotherapy and Immune Responses |
| h-index | 135 |
| i10-index | 431 |
| Last Known Institution | University of Pittsburgh |
| OpenAlex ID | https://openalex.org/A5024528047 |
| ORCID iD | https://orcid.org/0000-0003-3988-5419 |
| Works | 896 |

## Researcher papers

- [Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma](https://scholariq.org/papers/use-of-tumor-infiltrating-lymphocytes-and-interleukin-2-in-the-immunotherapy-of/)
- [Autophagy promotes ferroptosis by degradation of ferritin](https://scholariq.org/papers/autophagy-promotes-ferroptosis-by-degradation-of-ferritin/)
- [HMGB1 in health and disease](https://scholariq.org/papers/hmgb1-in-health-and-disease/)
- [AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc– Activity](https://scholariq.org/papers/ampk-mediated-becn1-phosphorylation-promotes-ferroptosis-by-directly-blocking/)
- [The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity](https://scholariq.org/papers/the-grateful-dead-damage-associated-molecular-pattern-molecules-and-reduction/)
- [RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation](https://scholariq.org/papers/rage-receptor-for-advanced-glycation-endproducts-rage-ligands-and-their-role-in/)
- [HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells](https://scholariq.org/papers/hspa5-regulates-ferroptotic-cell-death-in-cancer-cells/)
- [High-mobility group box 1 and cancer](https://scholariq.org/papers/high-mobility-group-box-1-and-cancer/)
- [Cancer and Inflammation: Promise for Biologic Therapy](https://scholariq.org/papers/cancer-and-inflammation-promise-for-biologic-therapy/)
- [INTERLEUKIN-1F7B (IL-1H4/IL-1F7) IS PROCESSED BY CASPASE-1 AND MATURE IL-1F7B BINDS TO THE IL-18 RECEPTOR BUT DOES NOT INDUCE IFN-γ PRODUCTION](https://scholariq.org/papers/interleukin-1f7b-il-1h4-il-1f7-is-processed-by-caspase-1-and-mature-il-1f7b/)
- [First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas](https://scholariq.org/papers/first-in-human-phase-i-study-of-copanlisib-bay-80-6946-an-intravenous-pan-class/)
- [Defining the critical hurdles in cancer immunotherapy](https://scholariq.org/papers/defining-the-critical-hurdles-in-cancer-immunotherapy/)

## Researcher topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Autophagy in Disease and Therapy](https://scholariq.org/topics/autophagy-in-disease-and-therapy/)

## Researcher university

- [University of Pittsburgh](https://scholariq.org/institutions/university-of-pittsburgh/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.